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Palliative care is effective: But hospital symptom outcomes superior
Abstract
Objectives: To explore differences in severe symptom outcomes for palliative care patients receiving hospital
care compared with those receiving care at home.
Methods: Change in symptom distress from the start of an episode of palliative care to just prior to death was
measured for 25 679 patients who died under the care of a hospital or home-based palliative care team
between January 2015 and December 2016. Logistic regression models controlled for differences between
hospital and home and enabled a comparison of the number of severe symptoms just prior to death.
Results: All symptoms improved and over 85% of all patients had no severe symptoms prior to death. Pain
control illustrates this with 7.4% of patients reporting severe pain distress at episode start and 2.5% just prior
to death. When comparing all symptom outcomes by place of death, hospital patients are 3.7 times more
likely than home patients to have no severe symptoms.
Conclusion: Symptom outcomes are better for hospital patients. Patients at home have less improvement
overall and some symptoms get worse. Reasons for the difference in outcomes by hospital and home are
multifactorial and must be considered in relation to the patient's right to choose their place of care.
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AbstrAct
Objectives To explore differences in severe 
symptom outcomes for palliative care patients 
receiving hospital care compared with those 
receiving care at home.
Methods Change in symptom distress from the 
start of an episode of palliative care to just prior 
to death was measured for 25 679 patients who 
died under the care of a hospital or home-based 
palliative care team between January 2015 and 
December 2016. Logistic regression models 
controlled for differences between hospital and 
home and enabled a comparison of the number 
of severe symptoms just prior to death.
results All symptoms improved and over 85% 
of all patients had no severe symptoms prior to 
death. Pain control illustrates this with 7.4% of 
patients reporting severe pain distress at episode 
start and 2.5% just prior to death. When 
comparing all symptom outcomes by place of 
death, hospital patients are 3.7 times more likely 
than home patients to have no severe symptoms.
conclusion  Symptom outcomes are better 
for hospital patients. Patients at home have less 
improvement overall and some symptoms get 
worse. Reasons for the difference in outcomes 
by hospital and home are multifactorial and must 
be considered in relation to the patient’s right to 
choose their place of care.
Across the healthcare spectrum, patients 
and their families need evidence in order 
to make informed choices about their care 
needs. Palliative care is no exception, and 
Australia is in a unique position interna-
tionally to provide such evidence.
The Australian Palliative Care Outcomes 
Collaboration (PCOC) is a national 
programme for palliative care services to 
routinely measure and benchmark patient 
outcomes.1 PCOC holds information 
on the outcomes of more than 250 000 
Australians who have received palliative 
care over the last decade and the PCOC 
clinical assessment model is now firmly 
embedded into clinical practice at point 
of care. In 2016, the PCOC data collec-
tion represented 12.4% of all deaths in 
Australia (including unpredictable deaths) 
and more than 80% of all patients seen 
annually by specialist palliative care 
services. An important role of PCOC is to 
report on this repository of prospectively 
collected information. Previously, PCOC 
researchers have found that palliative care 
services achieve statistically significant 
improvements in pain and other symp-
toms2 and have described symptom prev-
alence at the time dying is diagnosed.3 In 
those previous studies, the palliative care 
phase2 3 was the unit of counting with the 
outcome being the change from the begin-
ning to the end of each phase.
Data presented here examine, for the 
first time, the change in symptom scores 
from the beginning of a palliative care 
episode to just prior to death. Episodes 
are defined by setting—either in a 
hospital/hospice or at home—and consist 
of one or more phases. The aim is to 
compare symptom outcomes for people 
receiving care in a hospital palliative care 
unit or hospice (henceforth referred to 
as a hospital episode) to those of people 
receiving care at home (a home episode).
MethOds
Over the last decade, palliative care 
services across Australia have embedded 
the PCOC clinical assessment frame-
work as part of routine care in both 
hospital and home settings.4 PCOC holds 
outcome data representing more than 45 
000 people receiving palliative care each 
year.5 6 Physical symptom outcomes are 
measured using the Symptom Assessment 
Scale (SAS).7 SAS measures symptom 
distress for each palliative care phase.8 
For this analysis, the first phase SAS scores 
are compared with final phase SAS scores 
collected just prior to death. The SAS is 
used by patients to rate distress relating 
to seven physical symptoms (difficulty 
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Table 1 Cohort characteristics
N 25 679
Female (%) 46.4
Malignant diagnosis (%) 81.5
Setting of care/place of death (%)
  Hospital palliative care unit/
hospice
75.1
  Home 20.4
  Residential aged care facility 4.0
  Community—not specified 0.5
Age (years)
  Mean 73.6
  SD 13.7
  Range 0–109
Table 2 Final palliative care phase type and length of phase 
prior to death
Entire cohort
Hospital (PCU/
hospice)
Community 
(home/racf/
other)
(N=25 679) (N=19 292) (N=6387)
Phase type (%)
  Stable 2.4 1.1 6.4
  Unstable 0.9 0.6 2.0
  Deteriorating 11.3 9.0 18.4
  Terminal 85.3 89.4 73.1
Time between 
first and last 
assessment 
(days)1
  Median 8 6 21
  IQR 3–21 2–15 7–54
Time between last 
assessment and 
death (days)
  Median 1 1 2
  IQR 1–3 1–3 1–5
sleeping, appetite problems, nausea, bowel problems, 
breathing problems, fatigue and pain). It is an 11-point 
numeric rating scale ranging from 0 (no distress) to 10 
(worst distress possible).1 7 In this study, only severe 
SAS scores, categorised as 8–10, are used. Data are 
collected directly from patients wherever possible, but 
if this is not possible, clinical assessment ratings are 
based on family/carers and clinical judgement. Proxy 
assessments are accepted as a fair substitute for patient 
responses when the patient is unable to contribute their 
own view.9 10 Patient psychological/spiritual distress as 
well as family/carer distress are included in the PCOC 
assessment protocol but are not reported here.
Symptoms distress outcomes are defined in this anal-
ysis as the change in the number of severe symptoms 
from the start to the end of an episode of care. In 
hospital, an episode of care is the continuous period 
of time from admission to death. In the community, 
it is the continuous time between first assessment and 
death. Patient episodes that end in transfer between 
settings are excluded, as are patients receiving advisory 
services from hospital consultation liaison teams.
The patient cohort includes all people who died 
receiving the care of a hospital or home-based palli-
ative care service between 1 January 2015 and 31 
December 2016 and who had both an assessment at 
episode start and another just prior to death. A require-
ment of inclusion in the study is that patients have data 
completion for both study time points.
Logistic regression was used to investigate the 
number of symptoms causing severe distress just prior 
to death, controlling for the initial number of severely 
distressing symptoms, setting of care (hospital/
home), age group, sex and life-limiting illness (cancer/
non-cancer). Having no severe symptoms just prior to 
death was the measure of interest.
All data analysis was undertaken using SAS software 
(SAS Institute, Cary, North Carolina, USA).
results
A total of 40 004 patients in the PCOC database 
died between January 2015 and December 2016. In 
total, 25 679 (64%) met the criteria for inclusion in 
this study and 14 365 (36%) did not. Episodes not 
meeting inclusion criteria had clinical assessment data 
at episode start but not at episode end. They fell into 
two categories. There were 1620 (4.0%) consultation 
liaison episodes. There were also 12 745 (31.8%) 
other episodes with symptoms measured only once at 
the start of the episode. These episodes were typically 
late referrals. The median episode length was 3 days (2 
days for hospital patients and 8 days for home patients) 
and 79% were in the deteriorating or terminal phase at 
their first (and only) assessment.
Table 1 shows the profile of the included patients. 
Hospital was the most common place of death, 
accounting for 76.6% of patients, with cancer being 
the main reason people were receiving palliative care 
(80%). In the overall PCOC data set, the distribution 
of episodes in hospital and home is roughly equal, but 
is skewed towards hospitals in this analysis as people 
are more likely to be admitted to hospital to die. This 
is consistent with PCOC data (not reported here) on 
the number of home palliative care episodes that end 
with the patient being transferred to hospital.
The median time between last assessment and death 
was 1 day in hospital and 2 days at home (table 2). 
Although there were some differences by place of 
death, the final phase was most likely to be the terminal 
phase (85.3%). The median time between the first and 
last assessment was 6 days for hospital/hospice and 21 
days for home (table 2).
Table 3 summarises the results of the logistic regres-
sion, modelling the number of severe symptoms 
just prior to death. When the other variables in the 
model are held constant, patients in the hospital are 
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Table 3 Summary of logistic regression results
OR 95% CI
Severe symptoms at 
start
  None 5.232 (4.907 to 5.578)
  One or more 1
Setting of care/place 
of death
Hospital palliative care 
unit / hospice
3.772 (3.534 to 4.027)
Home / residential aged 
care facility 
1
Age
  <55 1
  56–65 1.511 (1.349 to 1.693)
  66–75 2.283 (2.054 to 2.537)
  76–85 3.367 (3.033 to 3.739)
  86+ 3.916 (3.493 to 4.390)
Sex
  Female 0.958 (0.899 to 1.020)
  Male 1
Life-limiting illness
  Cancer 4.256 (3.980 to 4.550)
  Non-cancer 1
Figure 1 Severe symptoms at episode start and just prior to death.
3.7 times as likely than those at home to have no 
severely distressing symptoms just prior to death. Simi-
larly, patients with cancer are 4.3 times as likely than 
those with non-cancer diagnosis to have no severely 
distressing symptoms just prior to death.
One quarter of all palliative care patients (26.0%) 
reported having severe distress from at least one 
symptom at the start of their palliative care episode. 
This decreased to 13.9% just prior to death. Figure 1 
shows the percentage of patients reporting severe 
distress for each of the seven symptoms captured in the 
SAS tool. People in their final days and hours experi-
ence less pain and other problems than earlier in their 
illness. Fatigue is the most common symptom causing 
distress and is more common than pain. Breathing 
problems at end of life are also more common than 
pain. In total, 7.4% of patients reported severe distress 
from pain at episode start and only 2.5% in the last 
few days of life. Distress from fatigue and lack of 
appetite is not surprising as a loss of energy and appe-
tite is common as death approaches while most pain 
can be effectively managed. Other problems such as 
distress from bowel problems (constipation, diarrhoea, 
pain), difficulty sleeping and nausea are experienced 
less often and these also typically improve as death 
approaches.
discussiOn
Severe pain and symptom outcomes are better for 
hospital patients. Patients at home have less improve-
ment overall and some symptoms get worse. Pain and 
symptom control are fundamental to palliative care. 
Pain and symptom control are key reasons for a palli-
ative care referral, and they are also core domains that 
patients and families use to judge the care that they 
receive. Our key findings are twofold. First, higher 
levels of severe symptom distress reported at the start 
of palliative care reduce significantly. Second, those 
who die at home experience less improvement overall 
and distress from fatigue and breathing problems get 
worse. The reasons for the increase in these symptoms 
may be due to environmental or individual factors or 
both.
Reasons for the differences in symptom outcomes 
between hospital and home are multifactorial. This 
cohort includes patients who choose their place of care 
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and their place of death as well as those who do not. 
Some elect home palliative care and a home death and 
some elect to be admitted to hospital at end of life. 
Other patients effectively have little choice because 
they are admitted to palliative care for terminal care 
due to factors such as late identification of needs and 
late referral to palliative care.
When physical symptoms exceed the intensity of 
care that can be delivered in the community, people are 
frequently admitted to hospital for symptom manage-
ment. National PCOC data confirm this with 74% 
patients being admitted to hospital in the unstable or 
deteriorating phase,5 an indication of higher symptom 
needs. In consequence, symptoms at the start of a 
hospital episode are more severe (figure 1) and there-
fore there is more room for improvement compared 
with home-based care.
Care at home requires families and healthcare 
professionals (including a family physician) to provide 
adequate support.11 12 For some patients, this might not 
be achievable on any sustainable basis. Not all commu-
nity palliative care can offer a rapid response service on 
a 24 hours 7 days basis and access to medical resources 
is often limited relative to availability in hospitals.
A person’s wishes and choices regarding end-of-
life care also impact their outcomes. Not everyone 
wants to go to hospital in their final stages of life and 
many people would prefer to be at home.13 14 Another 
consideration is that some people elect little or no 
pain relief and others elect to stay at home even if pain 
and symptom control might be better if they were in 
hospital.
cOnclusiOn
Australian palliative care is leading the world in 
having a national system of routine patient outcome 
measurement and benchmarking using point-of-care 
assessment of symptoms. The PCOC data demonstrate 
that those receiving care in a hospital with designated 
palliative care services have better pain and symptom 
control than those receiving palliative care at home.6 
This current analysis lends further weight to this 
conclusion.
This study raises a number of issues for further 
exploration. This includes the need to undertake 
further work exploring the impact of proxy scores on 
symptom outcomes as final ratings just prior to death 
are more likely to be provided by proxies. This work is 
already in progress.
Although it is difficult in an observational study 
to attribute change to an intervention, the results 
presented here are consistent with PCOC data 
collected nationally for more than a decade, which 
show both significant improvement nationally year on 
year while at the same time finding consistently better 
symptom management in the hospital setting. Signifi-
cant work is now in progress to better understand the 
effect of model of care and resources on outcomes in 
both settings. This includes an exploration of service 
level features that lead to improvement, including the 
relationship between key service characteristics and 
outcomes.
While it is not possible to be definitive about the 
reasons for the difference in outcomes between hospital 
and home, a better understanding of this is crucial for 
policy and service development. Differences in patient 
outcomes need to be taken into account in formulating 
national palliative care policies and in service planning. 
At the clinical level, this information is critical to allow 
patients and families to make informed choices about 
the best place for their care.
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